vs
Side-by-side financial comparison of BIOMERICA INC (BMRA) and Lakeshore Acquisition III Corp. (LCCC). Click either name above to swap in a different company.
BIOMERICA INC is the larger business by last-quarter revenue ($1.2M vs $717.3K, roughly 1.7× Lakeshore Acquisition III Corp.). Lakeshore Acquisition III Corp. runs the higher net margin — 67.9% vs -109.1%, a 177.0% gap on every dollar of revenue.
Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.
BMRA vs LCCC — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $717.3K |
| Net Profit | $-1.3M | $486.8K |
| Gross Margin | 4.2% | — |
| Operating Margin | -113.5% | -32.1% |
| Net Margin | -109.1% | 67.9% |
| Revenue YoY | -26.0% | — |
| Net Profit YoY | -38.9% | — |
| EPS (diluted) | $-0.45 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.4M | $717.3K | ||
| Q2 25 | — | $467.3K | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $1.0M | — |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $2.0K | $486.8K | ||
| Q2 25 | — | $216.5K | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-950.0K | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-1.9M | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 26.7% | — | ||
| Q3 24 | 16.0% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -14.7% | — |
| Q4 25 | -113.5% | — | ||
| Q3 25 | -81.0% | -32.1% | ||
| Q2 25 | — | -53.7% | ||
| Q1 25 | -108.1% | — | ||
| Q4 24 | -60.7% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -136.6% | — | ||
| Q1 24 | -196.7% | — |
| Q4 25 | -109.1% | — | ||
| Q3 25 | 0.1% | 67.9% | ||
| Q2 25 | — | 46.3% | ||
| Q1 25 | -103.9% | — | ||
| Q4 24 | -58.1% | — | ||
| Q3 24 | -72.8% | — | ||
| Q2 24 | -127.1% | — | ||
| Q1 24 | -188.6% | — |
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $0.00 | $0.08 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | $-0.48 | — | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $-0.63 | — | ||
| Q2 24 | $-2.57 | — | ||
| Q1 24 | $-0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4M | $-1.6M |
| Total Assets | $6.0M | $71.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5M | — | ||
| Q3 25 | $3.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $2.8M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $5.3M | — |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $5.2M | $-1.6M | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $5.3M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $7.8M | — |
| Q4 25 | $6.0M | — | ||
| Q3 25 | $6.9M | $71.0M | ||
| Q2 25 | — | $70.5M | ||
| Q1 25 | $7.4M | — | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $10.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-991.0K | $-206.3K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.42× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-991.0K | — | ||
| Q3 25 | $-268.0K | $-206.3K | ||
| Q2 25 | — | $-218.3K | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $-791.0K | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -95.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | -134.00× | -0.42× | ||
| Q2 25 | — | -1.01× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
